Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Trading 07-30 12:00:59 EDT

965.99

-22.89

-2.31%

High988.88	Low961.13	Vol613.13M
Open988.88	D1 Closing988.88	Amplitude2.81%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O6.21B	T/O Rate--	Tradable Shares0.00
P/B5.801902	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":965.9925,"timestamp":1785427259071,"preClose":988.8836,"halted":0,"volume":613128966,"delay":0,"changeRate":-0.023148,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-22.891113,"latestTime":"07-30 12:00:59 EDT","open":988.8836,"high":988.8836,"low":961.13135,"amount":6210435762.93627,"amplitude":0.028064,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785441600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.801902,"peRate":30.406316,"turnoverRate":0.013808,"increases":123,"decrements":63,"flats":3,"marketCap":3751722015420.875,"floatMarketCap":3590750014225.7188},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2655228258","title":"Sanofi's New CEO Might be Done with Major Portfolio Pruning","url":"https://stock-news.laohu8.com/highlight/detail?id=2655228258","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655228258?lang=en_us&edition=fundamental","pubTime":"2026-07-30 16:44","pubTimestamp":1785401040,"startTime":"0","endTime":"0","summary":"0843 GMT - Sanofi's major portfolio pruning might be over after the French drugmaker dropped several experimental drugs since the appointment of Belen Garijo as CEO, Bernstein analysts say in a research note. \"Whilst the new CEO's overall pipeline assessment is still ongoing, we understand that no additional large phase 3 discontinuations--beyond what have already been announced since the new CEO joined in early May--are now planned,\" the analysts say. Sanofi's 2030 sales targets suggest consensus estimates could be upgraded by mid-single digit percentages, according to Bernstein. Shares fall 3.4%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SNY","SNYNF","IE00BFXG1179.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655246178","title":"LeonaBio upgraded to Outperform from Market Perform at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2655246178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655246178?lang=en_us&edition=fundamental","pubTime":"2026-07-30 16:40","pubTimestamp":1785400817,"startTime":"0","endTime":"0","summary":"Citizens analyst Jason Butler upgraded LeonaBio (LONA) to Outperform from Market Perform with an $18 price target The firm says the company’s lasof...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leonabio-upgraded-to-outperform-from-market-perform-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leonabio-upgraded-to-outperform-from-market-perform-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LONA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655282910","title":"Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $161 from $150","url":"https://stock-news.laohu8.com/highlight/detail?id=2655282910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655282910?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:55","pubTimestamp":1785398154,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nFWN43W1F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CORT","BK4532","FBT","LU0566484027.USD","LU1559883803.SGD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655829622","title":"Takeda Pharmaceutical Fiscal Q1 Core Earnings, Revenue Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2655829622","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655829622?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:45","pubTimestamp":1785397520,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  reported fiscal Q1 core earnings Thursday of 154 Japanese yen  per share, up from 151 yen a year earlier.Four analysts polled by FactSet expected 143.97 yen.Revenue for the quarter ended June 30 was 1.220 trillion, compared with 1.107 trillion yen a year earlier.Analysts expected 1.150 trillion yen.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YCL","TAK","BK4007","YCS","HEWJ","FXY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655296538","title":"Sanofi Might be Better Off Favoring Deals over Internal Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2655296538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655296538?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:42","pubTimestamp":1785397320,"startTime":"0","endTime":"0","summary":"0742 GMT - Sanofi's second-quarter results contain many changes after the arrival of a new CEO, but investors will likely focus on the company's plans for dealmaking and its internal research-and-development efforts, Intron Health's Naresh Chouhan and Dominic Rose say in a note. \"A bunch of drugs were killed in R&D, hopefully Sanofi materially cut internal R&D in favour of external [business development], in our view,\" the analysts say. The French drugmaker raised its full-year guidance after Dupixent--a blockbuster anti-inflammatory drug jointly developed with Regeneron Pharmaceuticals--beat expectations for the second quarter, they add. Sanofi upgraded its 2030 sales estimates for Dupixent, but lowered guidance for its vaccines business, so the changes are slightly worse for its net present value, the analysts say. Shares fall 2.4%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SNY","SNYNF","IE00BFXG1179.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655826433","title":"Is Eton Pharmaceuticals (ETON) Quietly Reframing Its Orphan-Drug Strategy With KHINDIVI’s Label Expansion Bid?","url":"https://stock-news.laohu8.com/highlight/detail?id=2655826433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655826433?lang=en_us&edition=fundamental","pubTime":"2026-07-30 15:21","pubTimestamp":1785396114,"startTime":"0","endTime":"0","summary":"Eton Pharmaceuticals has submitted a Prior Approval Supplement to the FDA seeking to extend KHINDIVI’s hydrocortisone oral solution label to younger pediatric patients with adrenocortical insufficiency, beyond its current approval for those aged five and older.\nThis move, backed by bioequivalence data versus ALKINDI SPRINKLE, could broaden treatment options in a rare disease population where Eton estimates about 10,000 U.S. pediatric patients.\nWith KHINDIVI already the only FDA-approved...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-eton-pharmaceuticals-eton-quietly-reframing-its-orphan-dr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eton/eton-pharmaceuticals/news/is-eton-pharmaceuticals-eton-quietly-reframing-its-orphan-dr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ETON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655825534","title":"Takeda Pharmaceutical Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $7.655B Beat $7.060B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655825534","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655825534?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:50","pubTimestamp":1785394228,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.39 by 23.08 percent. This is a 7.69 percent decrease over earnings of $0.52 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60787533/takeda-pharmaceutical-q1-adj-eps-0-48-beats-0-39-estimate-sales-7-655b-beat-7-060b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655782580","title":"Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2655782580","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655782580?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:48","pubTimestamp":1785394133,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics shares soared 21.95% after hours as strong quarterly results and raised guidance boosted investor confidence.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/07/60787510/corcept-therapeutics-shares-surge-after-hours-q2-results-raised-guidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4532","RSI","NUWE","BK4007","BETZ","PSCH","BK4150","ODDS","FBT","CORT","LU1559883803.SGD","LU0566484027.USD","ODDZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655982378","title":"Press Release: Takeda Announces Fy2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track","url":"https://stock-news.laohu8.com/highlight/detail?id=2655982378","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655982378?lang=en_us&edition=fundamental","pubTime":"2026-07-30 14:37","pubTimestamp":1785393420,"startTime":"0","endTime":"0","summary":"--  Solid first quarter performance broadly in line with guidance,underpinned by resilient demand across core in-line brands. --  Commercial execution and late-stage pipeline investments on schedule,including first approval for ORZEYFULTM  in China, setting. exchange rate  basis and decreased by -0.5% on a Constant Exchange. Rate  basis as the negative impact of the loss of exclusivity of. by -0.5% on a CER basis, reflecting continued growth investments. --  Core EPS increased by +1.5% at AER and decreased by -11.8% at CER,Japan.Takeda President and Chief Executive Officer, Julie Kim, commented:\"Our solid performance this quarter marks a good start to the fiscal year and keeps us on track to achieve our full-year targets.\"This quarter's results reflect our unwavering commitment to financial discipline and the progressing execution of our enterprise transformation. The efficiencies unlocked by this ongoing program are directly fueling our highest priorities in Horizon One in our two-hor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4104","SG9999014013.SGD","LU0109981661.USD","PRGS","BK4022","TAK","LU0211331839.USD","LU1098665638.USD","R","SG9999014005.SGD","BK4232","BK4572","SG9999014039.USD","SG9999014021.USD","LU2065732104.USD","AER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655828861","title":"TAKAOKA TOKO Sets Out FY2026 Q1 Financial Overview for Its Energy Network Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2655828861","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655828861?lang=en_us&edition=fundamental","pubTime":"2026-07-30 13:52","pubTimestamp":1785390726,"startTime":"0","endTime":"0","summary":"TAKAOKA TOKO CO., LTD. ( ($JP:6617) ) just unveiled an announcement. TAKAOKA TOKO CO., LTD. operates in the energy infrastructure and power systems...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takaoka-toko-sets-out-fy2026-q1-financial-overview-for-its-energy-network-business?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takaoka-toko-sets-out-fy2026-q1-financial-overview-for-its-energy-network-business?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NFRX","BK4570","BK4007","JP","MDIV","RIFR","UMI","EIPX","ABLD","MLPY","XLEI","MLPB","AMLP","VRAI","PPI","EINC","WEEI","HALX","BK4585","BK4135","IMLP","MLPR","GII","IQRA","AMZA","ASET","NML","BKGI","ENFR","HIPS","DFRA","TBG","IGF","DIV","TOLZ","USAI","ALTY","GLIX","NFRA","BK4588","AMLX","MLPI","GARA","EIPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655842232","title":"Merck, Wellcome Partner with Global Health Group to Make Ebola Vaccine for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2655842232","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655842232?lang=en_us&edition=fundamental","pubTime":"2026-07-30 13:00","pubTimestamp":1785387600,"startTime":"0","endTime":"0","summary":"Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trialsCHICAGO, July 30 (Reuters)-Hilleman Laboratories, a Singapore-based joint venture between MerckMRK.Nand the gl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43V14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU1917777945.USD","LU0980610538.SGD","LU2433249047.HKD","LU0238689110.USD","LU1093756168.USD","LU0122379950.USD","LU2125909247.SGD","LU2361045086.USD","LU2125154778.USD","LU2361044865.SGD","LU2357627491.SGD","BK4007","LU2361044949.HKD","LU1066051811.HKD","IE0009355771.USD","IE00B2B36J28.USD","LU1934455194.USD","BK4533","IE00BSNM7G36.USD","RXL","BK4534","SG9999015341.SGD","LU0098860793.USD","LU1989771016.USD","LU1069347547.HKD","LU2461242641.AUD","IE00BLSP4239.USD","GDOC","LU1023059063.AUD","SG9999001176.USD","LU1035773651.USD","LU1571399168.USD","LU0234572021.USD","SG9999002224.SGD","LU1116320901.HKD","LU0320765489.SGD","LU0965508806.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1699723380.USD","LU1585245621.USD","LU0208291251.USD","IE00BN8TJ469.HKD","LU1066051225.USD","LU1116320737.USD","LU0265550946.USD","LU0130102774.USD","LU0432979614.USD","FTXH","LU0477156953.USD","SG9999001440.SGD","LU2023250504.SGD","IYH","LU0648001328.SGD","LU0942090050.USD","LU1934455277.USD","LU1430594728.SGD","SG9999014542.SGD","LU2106854487.HKD","LU2112291526.USD","LU0320765646.SGD","LU1061106388.HKD","SG9999014567.USD","FHLC","LU1934455863.HKD","SGXZ57979304.SGD","LU1057294990.SGD","LU1923622614.USD","IXJ","HRTS","IHE","LU0006306889.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU2023250843.SGD","LU0106261372.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU0965509101.SGD","IE00B4R5TH58.HKD","LU1941712264.USD","LU1066051498.USD","BK4559","LU1974910355.USD","BMED","LU2125909593.SGD","LU1162221912.USD","LU0124676726.USD","BK4588","LU0265550359.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU2491049909.HKD","LU1037948897.HKD","LU2089984988.USD","LU0985320562.USD","LU0130517989.USD","LU0689626769.HKD","LU1291159041.SGD","LU1093756325.SGD","MRK","LU0965509283.SGD","LU0868494708.USD","LU0070302665.USD","LU2491050154.USD","LU0965509010.AUD","SG9999014559.SGD","IE00B1BXHZ80.USD","LU2491050071.SGD","LU0868494617.USD","LU0266013472.USD","LU1989772840.SGD","JDOC","IE00BBT3K403.USD","LU1983299246.USD","SG9999002232.USD","SG9999015358.SGD","PPH","LU1989772923.USD","SG9999001176.SGD","BK4550","LU2360032135.SGD","LU1941712348.USD","LU0058720904.USD","PAWZ","TRUH","SG9999013999.USD","LU1929549753.HKD","LU2125154935.USD","BK4585","SG9999014575.USD","LU0289739699.SGD","BK4516","LU0211331839.USD","LU1201861249.SGD","IE0002141913.USD","LU0859254822.USD","VHT","LU1066053197.SGD","XLV","LU0203347892.USD","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655844701","title":"Quantum BioPharma Announces Closing of Debt Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2655844701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655844701?lang=en_us&edition=fundamental","pubTime":"2026-07-30 12:18","pubTimestamp":1785385080,"startTime":"0","endTime":"0","summary":"THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July  30, 2026  (G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335726/0/en/Quantum-BioPharma-Announces-Closing-of-Debt-Settlement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655841739","title":"Qyuns Therapeutics Partner Caldera to Merge with Synlogic","url":"https://stock-news.laohu8.com/highlight/detail?id=2655841739","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655841739?lang=en_us&edition=fundamental","pubTime":"2026-07-30 11:32","pubTimestamp":1785382325,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said its partner, Caldera Therapeutics, has agreed to merge with Synlogic in an all-stock transaction, according to a Wednesday Hong Kong bourse filing.The combined company is expected to list on the Nasdaq Capital Market under the ticker \"CALD.\"The deal is backed by a $278 million concurrent private placement to fund the development of QX030N/CLD-423 for ulcerative colitis, Crohn's disease and other immune-mediated diseases.Qyuns said it licensed global development and commercialization rights for QX030N/CLD-423 to Caldera in 2025 and currently holds about an 11.48% stake in the company.The merger is expected to close by early 2027, subject to shareholder, regulatory and other customary approvals.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK1161","LENZ","02509","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655056841","title":"5 Singapore REITs for Reliable Retirement Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2655056841","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655056841?lang=en_us&edition=fundamental","pubTime":"2026-07-30 11:30","pubTimestamp":1785382200,"startTime":"0","endTime":"0","summary":"Retirement investing is about generating dependable cash flow that can last for decades. These five Singapore REITs stand out for their resilient portfolios, sustainable distributions, and potential to provide reliable passive income throughout retirement.","market":"sg","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2026/07/Mapletree-Industrial-Trust-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2026/07/Mapletree-Industrial-Trust-300x200.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/5-singapore-reits-for-reliable-retirement-income/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/5-singapore-reits-for-reliable-retirement-income/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["YLDW","BK6137","CFA","RWX","BK4139","BK6133","PSCF","IVRA","BK7094","BK4127","BK6072","IQRA","ICR.AU","CFA.SI","DPU","JJJ.SI","J69U.SI","RJMG","RIET","GRI","BPRE","ME8U.SI","BK4550","DFRA","BK6134","MDIV","NTDU.SI","TRUR","SRU.SI","RNTY","BK6011","BK6131","BK6512","URE","C38U.SI","XHOA","C2PU.SI","BK6142","CLR.SI","BK4007","REIT","BK6108","GLS.SI","BK6082","8C8U.SI","SRT.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655612849","title":"Major Insider Move Signals Growing Confidence in Outlook Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2655612849","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655612849?lang=en_us&edition=fundamental","pubTime":"2026-07-30 10:05","pubTimestamp":1785377121,"startTime":"0","endTime":"0","summary":"New insider activity at Outlook Therapeutics ( ($OTLK) ) has taken place on July 29, 2026. Director Faisal Ghiath Sukhtian has strengthened his pos...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-outlook-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-outlook-therapeutics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655845522","title":"Roivant President, Immunovant CEO Eric Venker Sells USD 6.99 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655845522","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655845522?lang=en_us&edition=fundamental","pubTime":"2026-07-30 09:00","pubTimestamp":1785373245,"startTime":"0","endTime":"0","summary":"Roivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common sharesRoivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on July 27 at a weighted avera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL6q3Bq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4139","BK4585","BK4588","ROIV","IMVT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655845532","title":"Dow Jones Top Company Headlines at 9 PM ET: Samsung's Chip Earnings Push Net Profit to Record | Microsoft ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2655845532","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655845532?lang=en_us&edition=fundamental","pubTime":"2026-07-30 09:00","pubTimestamp":1785373200,"startTime":"0","endTime":"0","summary":"Samsung's Chip Earnings Push Net Profit to RecordSamsung Electronics' net profit surged 14-fold in the second quarter, as a stellar performance by its core semiconductor division, helped the technolog","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDGF","GB00BDT5M118.USD","LU0557290698.USD","LU1323610961.USD","SG9999014567.USD","RGR","LU1564329115.USD","LU1046421795.USD","MSFX","LU1244550577.SGD","LU2361044865.SGD","LU0208291251.USD","LU0787776722.HKD","LU0354030511.USD","LU2506951958.HKD","LU0056508442.USD","METU","LU2468319806.SGD","BK4127","XDAT","LU0097036916.USD","IE000M9KFDE8.USD","IE00B3S45H60.SGD","LU0417517546.SGD","FHLC","GXPC","IE00B19Z9505.USD","LU2360106780.USD","LU1267930573.SGD","BK4598","BK4567","SG9999001176.SGD","MEDX","IE00BHPRN162.USD","LU2430703095.HKD","BK4516","FBYY","LU0342679015.USD","LU2100268510.USD","LU0786609619.USD","LU0162691827.USD","LU1267930490.SGD","LU1261432733.SGD","LU2506951875.HKD","TYLG","LU0077335932.USD","LU1235295455.SGD","LU1032955483.USD","IE00BJTD4N35.SGD","IHE","LU2242649171.HKD","LU1720051108.HKD","HK0000914686.HKD","LU0266013472.USD","LU0310799852.SGD","LU1992135472.HKD","LU2360108059.USD","TTXU","LU0124676726.USD","BK4097","XLC","LU2552382132.HKD","LU2602419157.SGD","LU1035773651.USD","FTEC","LU1506573853.SGD","LU0456855351.SGD","LU2168564495.EUR","LU1815333072.USD","LU1400636657.SGD","LU0957791311.USD","IE000KEQY171.SGD","LU1061106388.HKD","LU0642271901.SGD","LU0878866978.SGD","LU1868836757.USD","LU2361045086.USD","LU2275660780.HKD","LU0314104364.USD","LU2417539215.USD","BK4209","LU0130102774.USD","SG9999015358.SGD","LU1935043023.USD","LU2404859667.USD","LU2458330243.SGD","LU0823434583.USD","LU0879622024.SGD","LU1267930730.SGD","LU0323591593.USD","CLIX","LU1823568750.SGD","LU0070217475.USD","LU2272731865.HKD","LU0203201768.USD","LU1712237335.SGD","LU1267930813.SGD","LU1585245621.USD","LU1880398554.USD","IE000MB6IJN5.SGD","TRUH","LU0133085943.USD","SG9999000418.SGD","LU2552382058.USD","IE00B42XCP33.USD","LU0314106906.USD","LU0672654240.SGD","HK0000304805.HKD","LU2236285917.USD","LU2746668974.SGD","SGXZ31699556.SGD","LU1814569148.SGD","IE0002141913.USD","HK0000532082.HKD","LU2896262040.SGD","LU1803068979.SGD","IE00B5949003.HKD","LU2237443895.HKD","IE00B2B36J28.USD","LU0859254822.USD","LU2756315318.SGD","LU2095319765.USD","LU0289941410.SGD","IE00B1BXHZ80.USD","IE00BD6J9T35.USD","IE00BLSP4239.USD","SG9999014898.SGD","LU0048584097.USD","LU1043141123.HKD","LU0345769631.USD","IE00BDCRKT87.USD","LU0061475181.USD","LU2471134952.CNY","IE00BMPRXR70.SGD","LU1674673428.USD","LU1989772923.USD","IE00BQXX3F31.USD","LU2360032135.SGD","LU2272731600.USD","SG9999014906.USD","LU1670710661.SGD","BK4543","FBY","LU2087625088.SGD","LU1923622614.USD","LU2092937148.SGD","BK4579","IE00B775SV38.USD","LU0316494557.USD","LU1435385759.SGD","LU1629891620.HKD","LU0444973449.USD","LU0466842654.USD","LU0823421416.USD","LU0511384066.AUD","LU1670711123.USD","LU2279689827.SGD","LU2461242641.AUD","LU0788109477.HKD","IXN","LU0957808578.USD","LU2242650005.HKD","LU1861559042.SGD","LU0960925559.SGD","LU0795875086.SGD","RSPC","IE000YTNTUN2.SGD","LU0345768740.USD","SG9999018857.SGD","BK4007","LU0210533765.USD","LU0965509283.SGD","LU1839511570.USD","LU2191332357.HKD","LU0211331839.USD","LU1127390331.HKD","LU0072461881.USD","LU0122379950.USD","LU1037948541.HKD","METW","IE00BMPRXN33.USD","LU1301847155.USD","LU1153585028.USD","LU2272731782.SGD","CVNA","LU2420271590.USD","SG9999015986.USD","LU0347712357.USD","SGXZ99366536.SGD","BK4214","LU1221951046.USD","LU0965508806.USD","LU0708995401.HKD","LU0127658192.USD","LU1894683264.USD","LU2087621335.USD","LU0823434740.USD","LU0689472784.USD","LU2463028550.USD","LU2097344431.USD","LU1340139317.AUD","SG9999017495.SGD","LU0708994859.HKD","BK4504","IE000BZT7R73.USD","LU2491050154.USD","META","LU1623119135.USD","LU1430594728.SGD","SUPL","LU2430703251.USD","SGXZ23171101.USD","LU2720916845.USD","LU2054465674.USD","LU2023250843.SGD","LU0690374961.EUR","LU2023251221.USD","LU0175139822.USD","LU0079474960.USD","LU1551013342.USD","LU0889566641.SGD","BK4547","TRUC","BK4535","LU1564329032.USD","IE0000B7K699.USD","FINX","LU0011850046.USD","LU2458330169.SGD","LU1691799644.USD","LU0820561818.USD","IE00B4R5TH58.HKD","LU1366192091.USD","BK4527","LU1983299246.USD","LU2471134879.HKD","BK4507","LU2237443465.HKD","LU0096364046.USD","IE00BGHQDM52.EUR","LU0726765562.USD","LU0354030438.USD","LU1564329628.SGD","LU2065171311.SGD","IE000ITXATA3.USD","LU0942090050.USD","IE00BZ1G4Q59.USD","LU0265550946.USD","IE0034235295.USD","LU0426412945.USD","JNJ","LU0138981039.USD","BK4573","IE0004091025.USD","LU0795875169.SGD","LU0225283273.USD","LU1989773731.SGD","LU2433249047.HKD","IE00BDGV0183.EUR","LU0289960550.SGD","BK4554","EFIV","IE0009356076.USD","VHT","LU1929549753.HKD","LU2041044095.USD","LU1564329461.SGD","IE00BKDWB100.SGD","LU2237957811.SGD","LU1989772840.SGD","LU3102509885.SGD","LU2237957902.USD","TDIV","LU2023250330.USD","TRFK","LU0494093205.USD","LU2065169927.USD","LU1032466523.USD","BK4566","LU1548497426.USD","IE00BJT1NW94.SGD","LU0345774631.USD","BPAY","LU0823421333.USD","BK4016","LU2129689605.HKD","LU0553294199.USD","LU0823417737.USD","LU0979878070.USD","IE00B3PB1722.GBP","LU0690374615.EUR","LU0345770993.USD","LU2063271972.USD","CMGG","LU2505996681.GBP","HOOZ","BK4587","CVNX","GDOC","PJP","FTXL","MSFW","CNEQ","LU0432979614.USD","SG9999015978.USD","LU0096362180.USD","LU0985489474.SGD","LU2471134523.USD","LU0072462426.USD","BK4548","LU1803068623.USD","TDV","HOOW","LU1228905037.USD","IE00BMPRXQ63.HKD","LU1236620750.USD","QCOM","LU1935042215.USD","LU2244417387.USD","CP","LU2089284900.SGD","LU2271345857.HKD","LU0289739699.SGD","LU1894683348.USD","LU1196500208.SGD","BK4576","LU1202635105.USD","IE00B19Z3B42.SGD","LU0320765646.SGD","LU2265009873.SGD","LU1934455194.USD","LU1951198990.SGD","LU1037948897.HKD","LU2592432038.USD","LU2133065610.SGD","IGV","HOOY","CVNY","LU0061474705.USD","LU1181866309.USD","QCMD","LU2452424414.USD","LU2168563687.JPY","IE00BFXG0V08.USD","LU1119994496.HKD","LU1642822529.SGD","LU1116320901.HKD","IE00B19Z8X17.USD","IXJ","LU0276348264.USD","LU0395794307.EUR","SG9999014542.SGD","LU2456880835.USD","LU0157215616.USD","LU1551013425.SGD","LU2473716301.USD","IE00B3T34201.USD","LU1988902786.USD","IE00BJJMRX11.SGD","LU0081259029.USD","ARMG","LU1066053197.SGD","IE0009G5SDU7.USD","BK4534","LU0820561909.HKD","LU0098860793.USD","SG9999002224.SGD","LU0154236417.USD","LU2487616109.SGD","LU2357627491.SGD","LTL","IE00B775H168.HKD","LU0345770308.USD","LU0476273544.USD","HOII","IE00BN29S564.USD","BK4190","SG9999014559.SGD","LU1732799900.SGD","IE000W1ABFV2.USD","LU1235294995.USD","SG9999013999.USD","LU2298321311.HKD","LU0868494708.USD","LU0171293334.USD","LU0210528500.USD","LU0312595415.SGD","LU1815336760.USD","MSFO","HOOD","LU1697837992.HKD","SG9999001424.SGD","HOOG","BK4609","LU1633808545.USD","LU0323240290.USD","LU0158827948.USD","LHX","LU1721428933.USD","LU0871640123.AUD","LU0106261372.USD","LU2362541513.USD","LU1582987324.SGD","LU0289739343.SGD","LU2065171402.SGD","LU0320765489.SGD","LU1699723380.USD","LU1989763005.USD","LU1280957306.USD","LU2750360641.GBP","SG9999015341.SGD","BILT","LU2322448957.HKD","LU0310800379.SGD","LU0724617625.USD","IE00B1XK9C88.USD","LU1917777945.USD","LU2211815571.USD","LU1718418525.SGD","LU1221951129.SGD","BK4575","LU1934455863.HKD","HOOI","IE00BDRTCR15.USD","BK4187","LU1983260115.SGD","SG9999015952.SGD","LU0345769128.USD","LU0345774391.USD","LU0211328371.USD","LU2637965513.SGD","LU2028103732.USD","ODDZ","QCML","LU0784383803.USD","LU1334329650.SGD","LU0058720904.USD","LU2404859741.USD","LU2129689431.USD","LU2403377893.USD","LU2413666699.HKD","LU0390134368.USD","LU1923623000.USD","LU0006061336.USD","PPC","LU2347655073.USD","LU2506952097.USD","IE00BJTD4V19.USD","LU0061474960.USD","LU2213496289.HKD","LU1868837136.USD","LU0640476718.USD","LU0198837287.USD","LU2237443622.USD","LU2106854487.HKD","LU0661504455.SGD","LU1400636574.HKD","LU1674673691.USD","LU2347655156.SGD","LU1244550221.USD","IE00B4JS1V06.HKD","LU1670627923.USD","LU2357305700.SGD","IE00B19Z3581.USD","VOX","LU2125909593.SGD","LU2168564065.EUR","LU1069344957.HKD","LU2362540622.SGD","FTXH","LU0289961442.SGD","LU0472753341.HKD","LU0006306889.USD","LU1861127337.USD","SPTE","LU2430703178.SGD","IE00BKPKM429.USD","LU0964807845.USD","BK4568","IE00BGHQF631.EUR","BK4561","LU0648001328.SGD","LU0426417589.USD","LU0444971666.USD","LU1188199696.SGD","LU2543165471.USD","LU2506952170.USD","LU0738911758.USD","BK4532","LU0912757837.SGD","BLCK","BK4539","HK0000819398.USD","LU2125909247.SGD","LU0784384876.USD","LU2237443978.SGD","LU0203202063.USD","LU1059921491.USD","IE00B19Z8W00.USD","LU1069347547.HKD","IE00BVYPNV92.GBP","LU0308772762.SGD","LU1242518857.USD","LU2381873111.SGD","IE00BFXG1179.USD","IPAV","LU0068578508.USD","LU1935042991.SGD","SG9999001077.SGD","LU0114720955.EUR","SGXZ51526630.SGD","IE00BYXW3230.USD","LU0210536198.USD","IE0009355771.USD","IE00BYQQ9H92.USD","LU2462157665.USD","BK4141","IE00B7SZLL34.SGD","LU2148611432.USD","LU0082616367.USD","LU1989764664.SGD","QQQA","LU0965509010.AUD","LU0985320562.USD","IE00BWXC8680.SGD","LU0965509101.SGD","LU2083900584.USD","IE00BFTCPJ56.SGD","LU2108987350.USD","IE00BSNM7G36.USD","BK4538","LU1043141396.HKD","IE0002270589.USD","LU2552382215.SGD","LU2764263203.CNY","LU1670756490.USD","BK4533","LU0792757196.USD","LU2264538146.SGD","LU2286300806.USD","LU1852331112.SGD","LU0545562505.USD","LU2168564149.EUR","MSFD","MSFU","LU1162221912.USD","LU1951200564.SGD","ROM","SGXZ81514606.USD","LU0882574055.USD","ARMW","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","LU0882574139.USD","LU0187121727.USD","BK4503","BK4585","BK4077","LU2210149790.SGD","LU0353189763.USD","LU2317271919.USD","LU0320765059.SGD","LU0861579265.USD","LU1066051811.HKD","LU1121112475.USD","MSFY","LU1645745479.HKD","IE00BJLML261.HKD","LU0894486033.HKD","SG9999018865.SGD","LU2023250504.SGD","LU1366333091.USD","IE00BVYPNP33.GBP","LU0528227936.USD","LU0069063385.USD","LU0949170426.SGD","LU0095938881.EUR","LU2746668461.USD","NULC","BK4559","LU0545039389.USD","LU1721429402.USD","IE00BFSS8Q28.SGD","LU0820562030.AUD","HOYY","LU0552385451.USD","LU2129689514.USD","SG9999014914.USD","ARMU","GB00B4LPDJ14.GBP","LU1935043536.SGD","LU1064131342.USD","LU0784385840.USD","LU1489326972.SGD","LU2125154935.USD","LU2047632596.USD","LU1571399168.USD","LU1582987597.SGD","LU2237438978.USD","LU1066051225.USD","LU1201861249.SGD","LU1084165304.USD","RXL","LU1035775433.USD","LU1670710588.SGD","LU1232071149.USD","LU1732800096.USD","LU2077746001.SGD","LU2247934214.USD","LU0170899867.USD","LU2112291526.USD","IE00BKVL7J92.USD","LU2471134796.USD","LU1720051017.SGD","LU0158827781.USD","LU1116320737.USD","LU0433182093.SGD","LU0868494617.USD","LU1791710400.SGD","LU0109391861.USD","LU0267386448.USD","LU0949170772.SGD","LU0080751232.USD","LU1670628061.USD","LU1778281490.HKD","BK4212","LU2089283258.USD","QCMU","LU1670711040.USD","SPRX","IE00BJJMRZ35.SGD","LU2326559502.SGD","SG9999001440.SGD","SG9999014575.USD","LU0211327993.USD","AIPI","CMG","HOOX","IE0001KFT4U8.USD","LU0348723411.USD","IE0003U64NQ7.SGD","LU0109392836.USD","LU0149725797.USD","XLV","IE0004445239.USD","IE00BBT3K403.USD","LU0234572021.USD","LU1868837300.USD","FSPC","LU1804176565.USD","SNPE","IE00BK4W5L77.USD","LU0094547139.USD","LU0107464264.USD","LU1242518931.SGD","IE0005OL40V9.USD","METV","LU0345768153.USD","LU1992135399.USD","LU1236620834.HKD","LU0302445910.USD","LU1496350502.SGD","LU2764262908.HKD","LU0889565833.HKD","LU1145028129.USD","LU1868836914.USD","LU2750360997.AUD","LU0238689110.USD","IE000SO60NU8.SGD","LU0719512351.SGD","LU1989763427.SGD","BK4550","SHPP","LU1974910355.USD","LU0980610538.SGD","LU2092937221.SGD","LU0323239441.USD","LU0256863811.USD","LU2168564222.USD","LU2237443549.SGD","LU1989764748.USD","LU0894485498.HKD","IE00BJJMRY28.SGD","LU1582986433.USD","FBL","LU0265550359.USD","LU1861558580.USD","LU2092627202.USD","IE000F7OJYX1.SGD","LU0203345920.USD","LU2237443382.USD","LU0353189680.USD","IE00B5TLWC47.USD","LU2097344357.USD","LU0994945656.USD","LU1914381329.SGD","MSFL","BK4592","IE00BVYPNQ40.USD","LU0234570918.USD","SG9999015945.SGD","LU2097829019.USD","BK4150","BMED","IE0034235188.USD","LU1228905540.USD","LU2111349929.HKD","METD","LU2065170008.USD","JDOC","LU0784385170.HKD","IE0004445015.USD","BK4604","LU2462591350.SGD","IE00B7KXQ091.USD","SG9999001176.USD","IE00BN8TJ469.HKD","LU1244550494.USD","LU0174119429.USD","LU2505996509.AUD","HK0000914660.USD","LU0950375773.USD","BK4528","BK4577","LU2250418816.HKD","LU0203347892.USD","GAMR","LU1880398471.USD","LU0757359368.USD","LU1791710582.SGD","LU1935042488.USD","LU2322448791.USD","LU2756315664.SGD","BK4581","BK4612","LU1496350171.SGD","XLK","LU0943347566.SGD","MGM","LU1003077747.HKD","IE00BK4W5M84.HKD","IE00BVYPNW00.USD","LU0029864427.USD","IE00BFSS7M15.SGD","LU1868836591.USD","LU2089984988.USD","SOCL","LU0215105999.USD","LU1074936037.SGD","CMAG","BK4525","LU1316542783.SGD","MSFT","LU2860962120.EUR","LU0689626769.HKD","LU1057294990.SGD","BK4515","CRPT","LU1429558221.USD","LU0683600562.USD","LU2491049909.HKD","LU0251132253.USD","BK4512","LU1400636491.USD","IE0004086264.USD","LU2491050071.SGD","LU2362541273.HKD","HK0000304797.USD","LU1721429741.USD","GB00B4QBRK32.GBP","LU0256863902.USD","LU1066051498.USD","SG9999002232.USD","LU0053666078.USD","LU0757359954.USD","ARM","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU1989763690.USD","IAI","HODU","IE00B4YYXB79.USD","LU2102340556.USD","LU1582986359.USD","SG9999014880.SGD","LU0057025933.USD","ROBN","BK4605","LU1934455277.USD","LU0070302665.USD","BK4524","LU0823417653.USD","LU0128525929.USD","LU2210150020.SGD","BK4588","SG9999004303.SGD","LU2764263039.SGD","LU2361044949.HKD","IE0034235303.USD","IE00B3SWFQ91.USD","LU1023059063.AUD","IE000WAW04H5.SGD","LU2125154778.USD","IYH","FCOM","LU2413666426.HKD","OGIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655843005","title":"New York City has paused construction at several office-to-apartment conversions since Pfizer tower structural problems","url":"https://stock-news.laohu8.com/highlight/detail?id=2655843005","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655843005?lang=en_us&edition=fundamental","pubTime":"2026-07-30 08:06","pubTimestamp":1785369991,"startTime":"0","endTime":"0","summary":"New York City is counting on office-to-apartment conversions to help relieve its housing shortage. But after structural problems earlier this month threatened a partial collapse at one of the city’s largest such projects, regulators have intensified scrutiny.Since then, three more Manhattan office conversion projects have been ordered to partially pause or halt construction this month over issues ranging from missing paperwork to cracks in concrete beams.Most recently, inspectors from New York City’s Department of Buildings issued a partial work stoppage this week at 750 Third Avenue after finding unapproved modifications to several steel columns in the building, according to an online database from the agency.The 34-story office tower, built in the 1950s, is undergoing a conversion into roughly 678 apartments, according to its architect, Gensler.The Tuesday inspection at 750 Third Avenue found several steel columns with welded splices, which are commonly used to join two pieces of ste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/07/29/business/office-apartment-conversions-paused-new-york","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/07/29/business/office-apartment-conversions-paused-new-york","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["LU1883839398.USD","LU0058720904.USD","LU0321505868.SGD","BK4533","LU1894683348.USD","LU0456855351.SGD","LU0122379950.USD","SG9999002224.SGD","LU0321505439.SGD","LU1066051498.USD","LU1894683264.USD","LU0234572021.USD","IE0002270589.USD","BK4581","BK4599","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4223","SLG","LU0225771236.USD","IE00B3T34201.USD","LU1066053197.SGD","PFE","SG9999013999.USD","LU0306806265.USD","SG9999001176.SGD","BK4007","IE00BLSP4239.USD","SG9999002232.USD","BK4550","BK4592","LU0868494617.USD","BK4534","SG9999003800.SGD","BK4568","IE00B19Z3581.USD","IE00BLSP4452.SGD","LU0306807586.USD","BK4585","DESK","LU0225284248.USD","LU1057294990.SGD","OZEM","SG9999001176.USD","IE00BBT3K403.USD","BK4588","SG9999011175.SGD","LU2596442595.SGD","LU0170899867.USD","SGXZ57979304.SGD","LU1023059063.AUD","BK4194","LU0289739699.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655848430","title":"Dexus Sells Brisbane CBD Tower to Free Capital and Tighten Gearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655848430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655848430?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:58","pubTimestamp":1785369508,"startTime":"0","endTime":"0","summary":"Dexus ( ($AU:DXS) ) has provided an update. Dexus has agreed to sell its 50% stake in the Premium-grade 480 Queen Street office tower in Brisbane’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dexus-sells-brisbane-cbd-tower-to-free-capital-and-tighten-gearing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dexus-sells-brisbane-cbd-tower-to-free-capital-and-tighten-gearing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","CBD","BK4113","ACB","BK4007","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192728417","title":"Over 90 Institutional REIT Applications Filed on Shanghai Stock Exchange, Exceeding 170 Billion Yuan in Total Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1192728417","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192728417?lang=en_us&edition=fundamental","pubTime":"2026-07-30 07:30","pubTimestamp":1785367839,"startTime":"0","endTime":"0","summary":"Institutional real estate investment trusts (REITs) are receiving increased policy backing. Recently, the Shanghai Stock Exchange (SSE) revised its rules, creating a special chapter for institutional...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRUR","CFA","GRI","SRT.SI","SRU.SI","URE","CFA.SI","BK4007","GLS.SI","RIET","XHOA","JJJ.SI","CLR.SI","BPRE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.015},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.1483},{"period":"ytd","weight":0.0697}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction